Quantcast
Last updated on April 21, 2014 at 1:20 EDT

Latest uterine fibroid Stories

2013-08-29 12:25:38

SAN DIEGO, Aug. 29, 2013 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced that the second Phase III pivotal trial to evaluate elagolix for the treatment of endometriosis has been initiated by AbbVie. This second Phase III trial is similar in design to the initial Phase III trial which is scheduled to provide top-line data in the third quarter of 2014 and complete in 2015. "We are pleased that the second Phase III study in endometriosis has been launched,"...

2013-08-27 23:33:38

DailyGossip.org reviews the newest and one of the most appreciated natural treatments for fibroids, at the moment. The treatment, "Fibroids Miracle", is described as a highly effective natural cure. Denver, Colorado (PRWEB) August 26, 2013 According to the Fibroids Miracle review published by DailyGossip.org on August 26, this new treatment is effective and patients who tried it were able to overcome the disease. http://www.DailyGossip.org reveals that the new method was...

2013-08-23 16:23:30

Beverly Hills Physician's range of gynecological services includes labial reduction, vaginal rejuvenation, and uterine fibroid treatment, performed by board-certified leaders in the field LOS ANGELES, Aug. 23, 2013 /PRNewswire/ -- In addition to labial reduction surgery and vaginal rejuvenation procedures, one of the most common gynecological surgeries sought out at Beverly Hills Physicians is uterine fibroid treatment. This is why Beverly Hills Physicians, an extensive medical...

2013-08-22 23:00:46

Daily Gossip reviews one of the latest natural fibroids treatments. The Fibroids Miracle Review presents a simple, yet really efficient cure for fibroids. Denver, Colorado (PRWEB) August 22, 2013 According to the review published by http://www.DailyGossip.org on August 23, Fibroids Miracle System is an eBook released by famous medical researcher, Amanda Leto. Amanda Leto found a new natural cure for Fibroids, which makes pills and medical interventions such as surgery completely...

2013-08-22 08:27:00

Third generation ExAblate system, using non-invasive MR guided Focused Ultrasound (MRgFUS) now available for Canadian patients TIRAT CARMEL, Israel, August 22, 2013 /PRNewswire/ -- InSightec Ltd, the leader in MR guided Focused Ultrasound therapy, announced that its ExAblate system received approval of Health Canada for MRgFUS treatment of uterine fibroids and for pain palliation of bone metastases. ExAblate combines high intensity focused ultrasound waves and continuous...

2013-08-21 04:21:29

LIVERMORE, Calif., Aug. 21, 2013 /PRNewswire/ -- Halt Medical, Inc. announced today that Brigham and Women's Faulkner Hospital is the first hospital in New England to treat patients with the Acessa Procedure. The Acessa Procedure is a new minimally invasive, same-day (outpatient) therapy for fibroids of all types and sizes, in all locations within the uterine wall. It uses a technology called radiofrequency ablation. Each fibroid is destroyed by applying energy through a small...

2013-07-29 04:21:12

TIRAT CARMEL, Israel, July 29, 2013 /PRNewswire/ -- Non-invasive MR guided Focused Ultrasound treatment now available for millions of Chinese women suffering from uterine fibroids InSightec Ltd, the leader in MR guided Focused Ultrasound therapy, announced that its ExAblate system received approval of the Chinese Food and Drug Administration (CFDA) for non-invasive treatment of uterine fibroids. Uterine fibroids are benign tumors that...

2013-07-25 16:25:34

VMAT2 PHASE IIB KINECT STUDY FULLY ENROLLED, TOP-LINE DATA IN SEPTEMBER SAN DIEGO, July 25, 2013 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced its financial results for the quarter ended June 30, 2013. For the second quarter of 2013, the Company reported a net loss of $12.2 million, or $0.18 loss per share, compared to a net loss of $0.5 million, or $0.01 loss per share, for the same period in 2012. For the six months ended June 30, 2013, the Company...

2013-07-25 04:21:28

LIVERMORE, Calif., July 25, 2013 /PRNewswire/ -- The Fibroid Treatment Collaborative, with centers in Chicago, IL and Austin TX, announced today the adoption of the Acessa Procedure as its primary surgical therapy for patients suffering from uterine fibroids. Traditional surgical interventions, such as hysterectomy or myomectomy, involve long recovery periods and other minimally invasive solutions may only treat symptoms, not the fibroids. "Fibroids are highly-symptomatic; causing...

2013-07-23 08:31:30

LYNBROOK, N.Y., July 23, 2013 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX(®) (collagenase clostridium histolyticum; CCH) in the U.S., announces that a poster titled, "Biomechanical Evaluation of Human Uterine Fibroids after Exposure to Purified Clostridial Collagenase" was presented today at the Society for the Study of Reproduction 46(th) Annual Meeting taking...